Skip to main content
Erschienen in: Virchows Archiv 5/2004

01.05.2004 | Case Report

Osteosarcoma occurring in osteogenesis imperfecta

verfasst von: Shu Takahashi, Kyoji Okada, Hiroyuki Nagasawa, Yoichi Shimada, Hitoshi Sakamoto, Eiji Itoi

Erschienen in: Virchows Archiv | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

We describe a case history of a 24-year-old male with osteogenesis imperfecta (OI) who developed osteosarcoma of the left thigh. High-dose ifosfamide therapy caused marked tumor regression of multiple lung metastases. Immunohistochemically, the tumor cells were diffusely positive for the p53 protein. Mutation of the p53 gene was not detected by direct genomic sequencing of exons 4–8. The radiographic characteristics, including irregularly distributed osteolytic lesions and cortical discontinuity, should not be confused with hyperplastic callus formation, a benign process. A biopsy is critical to establish the differential diagnosis between osteosarcoma and common hyperplastic callus formation in OI; however, it must be applied with great care.
Literatur
1.
Zurück zum Zitat Andreassen A, Oyjord T, Hovig E, Holm R, Florenes VA (1993) p53 abnormalities in different subtypes of human sarcomas. Cancer Res 53:468–471PubMed Andreassen A, Oyjord T, Hovig E, Holm R, Florenes VA (1993) p53 abnormalities in different subtypes of human sarcomas. Cancer Res 53:468–471PubMed
2.
Zurück zum Zitat Bedi HS, Kaufman DV, Choong PF, Slavin JL (1999) Osteosarcoma of the scapula arising in osteogenesis imperfecta. Pathology 31:52–54PubMed Bedi HS, Kaufman DV, Choong PF, Slavin JL (1999) Osteosarcoma of the scapula arising in osteogenesis imperfecta. Pathology 31:52–54PubMed
3.
Zurück zum Zitat Dorfman HD, Czerniak B (1998) Reactive and natabolic conditions simulating neoplasm of bone. Bone tumors. Mosby, Missouri, pp 1120–1194 Dorfman HD, Czerniak B (1998) Reactive and natabolic conditions simulating neoplasm of bone. Bone tumors. Mosby, Missouri, pp 1120–1194
4.
Zurück zum Zitat Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P (1996) Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14:467–472PubMed Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P (1996) Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14:467–472PubMed
5.
Zurück zum Zitat Gagliardi JA, Evans EM, Chandnani VP, Myers JB, Pacheco CM (1995) Osteogenesis imperfecta complicated by osteosarcoma. Skeletal Radiol 24:308–310PubMed Gagliardi JA, Evans EM, Chandnani VP, Myers JB, Pacheco CM (1995) Osteogenesis imperfecta complicated by osteosarcoma. Skeletal Radiol 24:308–310PubMed
6.
Zurück zum Zitat Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878PubMed Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878PubMed
7.
Zurück zum Zitat Hall PA, Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry?—Revisited! J Pathol 172:1–4 Hall PA, Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry?—Revisited! J Pathol 172:1–4
8.
Zurück zum Zitat Jewell FC (1940) Osteogenic sarcoma occurring in fragilitas ossium. Radiology 34:741–743 Jewell FC (1940) Osteogenic sarcoma occurring in fragilitas ossium. Radiology 34:741–743
9.
Zurück zum Zitat Klenerman L, Ockenden BG, Townsend AC (1967) Osteosarcoma occurring in osteogenesis imperfecta. Report of two cases. J Bone Joint Surg 49:314–323 Klenerman L, Ockenden BG, Townsend AC (1967) Osteosarcoma occurring in osteogenesis imperfecta. Report of two cases. J Bone Joint Surg 49:314–323
10.
Zurück zum Zitat Lasson U, Harms D, Wiedemann HR (1978) Osteogenic sarcoma complicating osteogenesis imperfecta tarda. Eur J Pediatr 129:215–218PubMed Lasson U, Harms D, Wiedemann HR (1978) Osteogenic sarcoma complicating osteogenesis imperfecta tarda. Eur J Pediatr 129:215–218PubMed
11.
Zurück zum Zitat Maiya S, Grimer RJ, Ramaswamy R, Deshmukh NS (2002) Osteosarcoma occurring in osteogenesis imperfecta tarda. Int Orthop 26:126–128CrossRefPubMed Maiya S, Grimer RJ, Ramaswamy R, Deshmukh NS (2002) Osteosarcoma occurring in osteogenesis imperfecta tarda. Int Orthop 26:126–128CrossRefPubMed
12.
Zurück zum Zitat Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950–7954PubMed Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950–7954PubMed
13.
Zurück zum Zitat Miller CW, Aslo A, Campbell MJ, Kawamata N, Lampkin BC (1996) Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet Cytogenet 86:136–142CrossRefPubMed Miller CW, Aslo A, Campbell MJ, Kawamata N, Lampkin BC (1996) Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet Cytogenet 86:136–142CrossRefPubMed
14.
Zurück zum Zitat Miller CW, Aslo A, Won A, Tan M, Lampkin B (1996) Alterations of the p53, Rb and MDM 2 genes in osteosarcoma. J Cancer Res Clin Oncol 122:559–565PubMed Miller CW, Aslo A, Won A, Tan M, Lampkin B (1996) Alterations of the p53, Rb and MDM 2 genes in osteosarcoma. J Cancer Res Clin Oncol 122:559–565PubMed
15.
Zurück zum Zitat Mousses S, McAuley L, Bell RS, Kandel R, Andrulis IL (1996) Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod Pathol 9:1–6PubMed Mousses S, McAuley L, Bell RS, Kandel R, Andrulis IL (1996) Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod Pathol 9:1–6PubMed
16.
Zurück zum Zitat Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ (1996) Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63:37–50CrossRefPubMed Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ (1996) Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63:37–50CrossRefPubMed
17.
Zurück zum Zitat Pritchard DJ, Finkel MP, Reilly CA Jr (1975) The etiology of osteosarcoma. A review of current considerations. Clin Orthop 111:14–22PubMed Pritchard DJ, Finkel MP, Reilly CA Jr (1975) The etiology of osteosarcoma. A review of current considerations. Clin Orthop 111:14–22PubMed
18.
Zurück zum Zitat Reid BS, Hubbard JD (1979) Osteosarcoma arising in osteogenesis imperfecta. Pediatr Radiol 8:110–112PubMed Reid BS, Hubbard JD (1979) Osteosarcoma arising in osteogenesis imperfecta. Pediatr Radiol 8:110–112PubMed
19.
Zurück zum Zitat Rutkowski R, Resnick P, McMaster JH (1979) Osteosarcoma occurring in osteogenesis imperfecta. A case report. J Bone Joint Surg Am 61:606–608PubMed Rutkowski R, Resnick P, McMaster JH (1979) Osteosarcoma occurring in osteogenesis imperfecta. A case report. J Bone Joint Surg Am 61:606–608PubMed
20.
Zurück zum Zitat Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194–6199PubMed Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH (1992) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194–6199PubMed
21.
Zurück zum Zitat Unni KK (1996) Conditions that commonly simulate primary neoplasm of bone. Dahlin’s bone tumors: general aspects and data on 11087 cases, 5th edn. Lippincott-Raven, New York, pp 355–432 Unni KK (1996) Conditions that commonly simulate primary neoplasm of bone. Dahlin’s bone tumors: general aspects and data on 11087 cases, 5th edn. Lippincott-Raven, New York, pp 355–432
Metadaten
Titel
Osteosarcoma occurring in osteogenesis imperfecta
verfasst von
Shu Takahashi
Kyoji Okada
Hiroyuki Nagasawa
Yoichi Shimada
Hitoshi Sakamoto
Eiji Itoi
Publikationsdatum
01.05.2004
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 5/2004
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-004-0985-5

Weitere Artikel der Ausgabe 5/2004

Virchows Archiv 5/2004 Zur Ausgabe

Announcements

May 2004

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …